BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 17001689)

  • 1. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
    Singhatanadgit W; Salih V; Olsen I
    J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP.
    Singhatanadgit W; Salih V; Olsen I
    Bone; 2006 Nov; 39(5):1008-1017. PubMed ID: 16774854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Int J Biochem Cell Biol; 2006; 38(10):1794-807. PubMed ID: 16797218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2.
    Singhatanadgit W; Mordan N; Salih V; Olsen I
    Int J Biochem Cell Biol; 2008; 40(12):2854-64. PubMed ID: 18619554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous BMPR-IB signaling is required for early osteoblast differentiation of human bone cells.
    Singhatanadgit W; Olsen I
    In Vitro Cell Dev Biol Anim; 2011 Mar; 47(3):251-9. PubMed ID: 21136190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).
    Quarto N; Wan DC; Longaker MT
    Bone; 2008 Jun; 42(6):1040-52. PubMed ID: 18420480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.
    Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T
    Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
    Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
    J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
    Yeh LC; Betchel KP; Lee JC
    J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
    You L; Kruse FE; Pohl J; Völcker HE
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.
    Ide H; Yoshida T; Matsumoto N; Aoki K; Osada Y; Sugimura T; Terada M
    Cancer Res; 1997 Nov; 57(22):5022-7. PubMed ID: 9371496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
    Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
    J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.
    Chen D; Ji X; Harris MA; Feng JQ; Karsenty G; Celeste AJ; Rosen V; Mundy GR; Harris SE
    J Cell Biol; 1998 Jul; 142(1):295-305. PubMed ID: 9660882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of type I BMP receptors during early avian sympathetic ganglion development.
    McPherson CE; Varley JE; Maxwell GD
    Dev Biol; 2000 May; 221(1):220-32. PubMed ID: 10772803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
    Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
    Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
    Nickel J; Dreyer MK; Kirsch T; Sebald W
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.
    Ishidou Y; Kitajima I; Obama H; Maruyama I; Murata F; Imamura T; Yamada N; ten Dijke P; Miyazono K; Sakou T
    J Bone Miner Res; 1995 Nov; 10(11):1651-9. PubMed ID: 8592941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults.
    Abir R; Ben-Haroush A; Melamed N; Felz C; Krissi H; Fisch B
    Fertil Steril; 2008 May; 89(5 Suppl):1430-40. PubMed ID: 17624341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.